BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gencer M, Akbayır E, Şen M, Arsoy E, Yılmaz V, Bulut N, Tüzün E, Türkoğlu R. Serum orexin-A levels are associated with disease progression and motor impairment in multiple sclerosis. Neurol Sci 2019;40:1067-70. [DOI: 10.1007/s10072-019-3708-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Ferrazzano G, Crisafulli SG, Baione V, Tartaglia M, Cortese A, Frontoni M, Altieri M, Pauri F, Millefiorini E, Conte A. Early diagnosis of secondary progressive multiple sclerosis: focus on fluid and neurophysiological biomarkers. J Neurol 2021;268:3626-45. [PMID: 32504180 DOI: 10.1007/s00415-020-09964-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Wang XT, Yu H, Liu FT, Zhang C, Ma YH, Wang J, Dong Q, Tan L, Wang H, Yu JT. Associations of sleep disorders with cerebrospinal fluid α-synuclein in prodromal and early Parkinson's disease. J Neurol 2021. [PMID: 34605986 DOI: 10.1007/s00415-021-10812-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Anderson G, Rodriguez M, Reiter RJ. Multiple Sclerosis: Melatonin, Orexin, and Ceramide Interact with Platelet Activation Coagulation Factors and Gut-Microbiome-Derived Butyrate in the Circadian Dysregulation of Mitochondria in Glia and Immune Cells. Int J Mol Sci 2019;20:E5500. [PMID: 31694154 DOI: 10.3390/ijms20215500] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
4 Aranda ML, Narvaez O, Altschuler F, Calanni JS, González Fleitas MF, Sande PH, Dorfman D, Concha L, Rosenstein RE. Chronobiotic effect of melatonin in experimental optic neuritis. Neuropharmacology 2021;182:108401. [PMID: 33197466 DOI: 10.1016/j.neuropharm.2020.108401] [Reference Citation Analysis]
5 Fakhoury M, Salman I, Najjar W, Merhej G, Lawand N. The Lateral Hypothalamus: An Uncharted Territory for Processing Peripheral Neurogenic Inflammation. Front Neurosci 2020;14:101. [PMID: 32116534 DOI: 10.3389/fnins.2020.00101] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
6 Pallais JP, Kotz CM, Stanojlovic M. Orexin/hypocretinin in multiple sclerosis and experimental autoimmune encephalomyelitis. Neural Regen Res 2020;15:1039-40. [PMID: 31823881 DOI: 10.4103/1673-5374.270310] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Sağır F, Ersoy Tunalı N, Tombul T, Koral G, Çırak S, Yılmaz V, Türkoğlu R, Tüzün E. miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study. Genet Test Mol Biomarkers 2021;25:720-6. [PMID: 34788141 DOI: 10.1089/gtmb.2021.0183] [Reference Citation Analysis]
8 Türkoğlu R, Benbir G, Özyurt S, Arsoy E, Akbayır E, Turan S, Karadeniz D, Yılmaz V, Gencer M, Tüzün E. Sleep disturbance and cognitive decline in multiple sclerosis patients with isolated optic neuritis as the first demyelinating event. Int Ophthalmol 2020;40:151-8. [PMID: 31432354 DOI: 10.1007/s10792-019-01157-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Wang Q, Cao F, Wu Y. Orexinergic System in Neurodegenerative Diseases. Front Aging Neurosci 2021;13:713201. [PMID: 34483883 DOI: 10.3389/fnagi.2021.713201] [Reference Citation Analysis]
10 Kumar S, Behl T, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harassi A, Abdel-Daim MM, Bungau S. Exploring the Role of Orexinergic Neurons in Parkinson's Disease. Neurotox Res 2021. [PMID: 34495449 DOI: 10.1007/s12640-021-00411-4] [Reference Citation Analysis]
11 Anderson G, Maes M. Gut Dysbiosis Dysregulates Central and Systemic Homeostasis via Suboptimal Mitochondrial Function: Assessment, Treatment and Classification Implications. CTMC 2020;20:524-39. [DOI: 10.2174/1568026620666200131094445] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]